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Abstract
Background: Human resistance to re-infection with S. mansoni is correlated with high levels of
anti-soluble adult worm antigens (SWAP) IgE. Although it has been shown that IL-4 and IL-5 are
crucial in establishing IgE responses in vitro, the active in vivo production of these cytokines by T
cells, and the degree of polarization of Th2 vs. Th0 in human schistosomiasis is not known. To
address this question, we determined the frequency of IL-4 and IFN-γ  or IL-5 and IL-2 producing
lymphocytes from schistosomiasis patients with high or low levels of IgE anti-SWAP.
Results:  Our analysis showed that high and low IgE-producers responded equally to
schistosomiasis antigens as determined by proliferation. Moreover, patients from both groups
displayed similar percentages of circulating lymphocytes. However, high IgE-producers had an
increased percentage of activated CD4+ T cells as compared to the low IgE-producers. Moreover,
intracellular cytokine analysis, after short-term stimulation with anti-CD3/CD28 mAbs, showed
that IgE high-producers display an increase in the percentage of T lymphocytes expressing IL-4 and
IL-5 as compared to IgE low-responders. A coordinate control of the frequency of IL-4 and IL-5
producing lymphocytes in IgE high, but not IgE low-responders, was observed.
Conclusions: High IgE phenotype human schistosomiasis patients exhibit a coordinate regulation
of IL-4 and IL-5 producing cells and the lymphocyte derived IL-4 comes from true polarized Th2
like cells, in the absence of measurable Th0 cells as measured by co-production of IL-4 and IFN-γ .
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Background
Schistosomiasis is a disease caused by a helminth parasite
and effects more than 200 million people. Infected indi-
viduals mount a strong proliferative response in vitro to
parasite antigens, and anti-worm and egg antibodies are
abundant as well [1,2]. Although effective treatment is
available, due to socio-economical conditions of the en-
demic countries, re-infection is highly prevalent and may
lead to the establishment of pathology.
Correlations have been made between intensity of infec-
tion and anti-parasite IgE antibody responses in human
schistosomiasis [3]. It has been shown that patients with
high levels of circulating IgE anti-SWAP are resistant to re-
infection [4–7]. Further studies demonstrated that this
immunoglobulin isotype, correlated with resistance to re-
infection, was mainly directed to a specific component of
SWAP, the sm22 antigen [8]. Moreover, individuals who
live in an endemic area, but were never infected with S.
mansoni, display high levels of anti-parasite IgE [9]. Early
studies on IL-4 function have demonstrated its ability in
eliciting IgE class switching [10]. Thus, it is possible that a
Th2-like regulation may be involved in the development
of resistance to re-infection in schistosomiasis, through
the induction of high levels of protective IgE. Moreover,
IL-5, a Th2-derived cytokine, is critical in the generation of
eosinophils, which are involved in mechanisms that lead
to protection in human and experimental schistosomiasis
[11,12].
Many mouse model systems have been used to study the
interaction of the immune system with S. mansoni, and
the data are mixed as to the role of Th1 and Th2 type re-
sponses in the development of protection, progression of
pathology, and establishment of granulomas [13,14]. Fur-
thermore, the role that IgE may play in experimental in-
fections is, with respect to the role of Th1/Th2
populations, controversial. While it has been shown that
IgE deficient mice or anti-IgE treated mice have higher
worm burden, granuloma formation is modulated in
these mice [15]. Furthermore, recent studies have demon-
strated that blocking of IL-13, a Th2 derived cytokine, is
accompanied by a decrease in the levels of total IgE and
modulation of pulmonary granuloma formation [16].
Correlation between high IL-4 levels and elevated IgE pro-
duction in conditions such as allergic reactions is well es-
tablished in the literature [17]. However, most studies
demonstrating the involvement of IL-4 in IgE responses
have been performed in vitro, demonstrating the ability of
the cells to produce IL-4 upon stimulation in culture.
Whether these cells are actively controlling the immune
profile in vivo, and are actively required to maintain the
IgE production remains to be directly addressed. In the
present study we performed an ex vivo analysis of cytokine
production by lymphocytes isolated from schistosomiasis
patients that produced high or low levels of IgE anti-
SWAP. To determine the nature of the active immunoreg-
ulation taking place in these infected patients, we per-
formed an analysis of the cytokine expression pattern and
frequency of cytokine expressing lymphocytes for key Th1
and Th2 associated cytokines. These cytokine expression
patterns and frequencies were then compared to the im-
muno-phenotype of high or low anti-SWAP IgE.
Results
PBMC from IgE-high and low producers mounted equiva-
lent proliferative responses to S. mansoni antigens
PBMC from both groups were simulated for five days and
proliferation measured by 3H-Thymidine uptake. As
shown in figure 1, the responses of the two groups was in-
tense to both SEA and SWAP, with no statistically signifi-
cant differences between the two (p = 0.1). The response
of the two groups to the positive control, SEB, demon-
strated the potential of each individual to mount an
equally strong T cell response independent of their group
definition and the nature of schistosoma-related antigen.
IgE high responder patients expressed a higher frequency 
of activated CD4+ T cells than the IgE low responders
Lymphocytes from patients of both groups were com-
pared for percentage of cells expressing CD4, CD8, CD19,
and for co-expression of the activation marker HLA-DR in
the CD4+ and CD8+ T cell populations. Figure 2 demon-
Figure 1
Proliferative response of PBMC from IgE high and
low responder groups. PBMC were stimulated in vitro with
SEA (25 ug/ml), SWAP (25 ug/ml), and the superantigen posi-
tive control, SEB (0.1 ug/ml). The bars represent the mean
proliferate response and standard error of the response.
None of the differences were statistically significant using stu-
dents T test.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/8
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strates that the percentage of CD4+, CD8+, or CD19+ cells
were not different between the two groups. However, the
percentage of activated CD4+ T cells was significantly
higher in the IgE high responder group.
IgE high responder individuals express a higher frequency 
of IL-4 and IL-5 producing lymphocytes, the former coming 
from exclusively Th2 like cells
In order to gain a better understanding of the immunoreg-
ulation and balance of cytokine production in these indi-
viduals, we performed single cell cytoplasmic staining
using two pairs of labeled antibodies as described in Ma-
terials and Methods. Figure 3 shows a representative dot-
plot of cytokine production by lymphocytes of high (A-C)
and low (D-F) -anti-SWAP IgE responders, demonstrating
the clearly defined cytokine-producing cell populations.
Moreover, it can be seen that greater than 90% of the IL-4
producing cells are polarized Th2 like cells, with little con-
tribution from Th0 cells as indicated by the lack of double
positive lymphocytes producing both IL-4 and IFN-γ  (Fig-
ure 3B), confirming the polarization of Th2 type cells in
these individuals.
As seen in figure 4, the IgE high responder group had a sig-
nificantly higher frequency of cells producing IL-4
(1.11%) and IL-5 (0.41%) after short term stimulation
with anti-CD3/CD28 mAbs than did the IgE low respond-
er group (0.31 and 0.09%, respectively). In contrast, the
IgE high and low responder groups did not differ in the
percentage of cells expressing IL-2 or IFN-γ  (Figure 4).
Non-stimulated controls showed undetectable levels of
all cytokines tested (data not shown).
A further analysis was performed looking at the ratio of
the percentage of cells expressing the Th2 type cytokine IL-
4, critical for IgE class switching, as compared to the per-
cent expressing the Th1 associated cytokine, IFN-γ . This ra-
tio was three times higher in the IgE high responding
group than the IgE low responding group (data not
shown).
Finally, when comparing the frequency of IL-4 and IL-5
producing cells in each individual from the high respond-
er and low responder anti-SWAP IgE group, we observed a
striking difference in the coordinate control of the fre-
quency of cytokine producing cells. As seen in figure 5, we
observed a strong coordinate control (c.c. = 0.93) of the
frequency of IL-4 and IL-5 producing lymphocytes only in
the high IgE anti-SWAP responders. Moreover, this rela-
tionship was not seen for the frequency of cells producing
IFN-γ  and IL-2 (Figure 5) for either of the groups.
Discussion
A vast number of studies have been performed in human
and experimental schistosomiasis in order to understand
the dynamics of interactions between host and parasite
and the pathological outcome of this complex relation-
ship. Several important findings have been acquired over
the past years but the exact mechanisms through which
pathology or resistance to infection is established are not
known. It is clear that the host's immune system plays a
key role in this decision. Early studies have demonstrated
that patients with different clinical forms of schistosomia-
sis respond in vitro to parasite antigens as well as to idio-
types [2,18–20]. Nonetheless, patients from different
endemic countries, or even different areas within the same
country, display distinct degrees of reactivity to a given an-
tigen or preferentially respond to different antigenic prep-
arations [21,22,19]. Also, cytokine production in human
schistosomiasis has been accessed in different systems
[23,24] and, to date, no definitive correlation between a
given cytokine profile and the development of pathology
or protection has been well established in human disease.
It has previously been shown that intestinal and hepat-
osplenic schistosomiasis patients display higher frequen-
cy of CD3+HLA-DR+ circulating cells, as compared to
non-infected individuals [25]. Moreover, it has been dem-
onstrated that activated T cells account for the production
of the majority of cytokines in the mouse [26]. Also, a
high frequency of activated T cell has been found in the
peripheral blood of individuals chronically infected with
Trypanosoma cruzi[27] and PBMC from these patients were
Figure 2
Ex vivo lymphocyte profile using flow cytometry
revealed a higher percent of activated CD4+ T cells
in the IgE high responder group. Lymphocytes freshly
isolated from whole blood were stained for the indicated
markers and the percent of cells in the lymphocyte gate
expressing each of the shown markers are diagrammed as
mean with the standard error. * p < 0.05 using the students T
test.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/8
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shown to produce high levels of immuno-regulatory cy-
tokines [28].
In our present study, patients with the high anti-SWAP IgE
phenotype displayed higher levels of T cell activation as
well as presented with higher frequency of IL-4 and IL-5
producing cells. Low IgE-responders displayed lower fre-
quency of activated CD4+ T cells and a lower frequency of
cells producing these cytokines. This suggests that active
production of IL-4 and IL-5 by T cells is maintaining the
IgE phenotype in these chronically infected individuals.
Interestingly, the differences in T cell activation and cy-
tokine production seen ex vivo in patients from each group
was not reflected in the proliferative responses or in the
frequency of IFN-γ  or IL-2 producing lymphocytes. More-
over, both groups, independent of anti-SWAP IgE levels,
had equivalent levels of anti-SWAP IgG.
IgE responses to parasite antigens have been shown to be
correlated with resistance to re-infection by many groups,
looking at patients from different geographical areas, as
well as infection by different schistosome species [7,29–
31]. Although induction of IgE responses have been corre-
lated with IL-4 production in other diseases [17], most
studies were performed in vitro, reflecting the potential of
IL-4 production but not accessing directly ex vivo the pro-
duction of this cytokine by lymphocytes. In this study, we
analyzed ex vivo, after short term stimulation with anti-
CD3/anti-CD28, the cytokine production by schisto-
somiasis patients that were classified based on their high
Figure 3
Th1 and Th2 cytokines are made by separate, Th1 and Th2 like cells, not by double producing, Th0 cells. Rep-
resentative cytokine production (IL-4 and IFN-γ  or IL-5 and IL-2) of total gated lymphocytes from high (A-C) or low IgE-pro-
ducers (D-F). Isotype controls show the lack of non-specific staining (A and D). The absence of double producing, IL-4+/IFN-
γ +, lymphocytes is evident in the high IgE group (B), with essentially all IL-4 producing cells being negative for IFN-γ  production.
In all cases, there is a clear segregation of IL-4 and IFN-γ  producing cells (B and E), or of IL-5 and IL-2 producing cells (C and F).BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/8
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or low production of anti-SWAP IgE. This approach gives
important information concerning the regulation of this
immunological profile previously correlated with resist-
ance, since it reveals a "picture" of cytokine production in
vivo. Moreover, considering that schistosomiasis is a
chronic disease, it is critical to understand whether cy-
tokines are important in establishing as well as in main-
taining a given phenotype. In the particular case of IgE
responses, it is well determined that IL-4 is a switch factor
for IgE but, whether it is critical for maintaining the re-
sponse for long periods of time is not necessarily a given
fact.
The short term stimulation used in our analysis was de-
signed to reveal the cytokine profile of the existing activat-
ed and/or memory cells without possible influences of
longer cultures. A recent study has used a similar approach
to determine cytokine profiles of individuals with allergy
or autoimmune diseases using, PMA/ionomycin as source
of stimulus [32]. Although PMA/ionomycin stimulation
leads to a higher frequency of cytokine-producing cells
(data not shown), it is less likely to only amplify and re-
veal the cytokine profile of lymphocytes seen in vivo than
anti-CD3/anti-CD28. Given our results and those of oth-
ers [33] PMA/Ionomycin can skew responses as well as
stimulate non-T cell populations. Thus, stimulation with
anti-CD3 plus anti-CD28 is a more physiologic stimuli
than PMA/Ionomycin.
Considering that IL-4 can also be produced by other cell
types, involved with innate immune responses that may
likely occur in the early phases of the disease, we can not
rule out the possibility that other sources of IL-4 would be
important for the initial production of IgE in vivo. Howev-
er, considering the crucial role of T cells in chronic infec-
tions, these results strongly suggest that the specific IgE
response seen in these patients is under the control of Th2
cells. Corroborating with this hypothesis, we directly
demonstrated in these studies a coordinate regulation of
the frequency of IL-4 and IL-5 producing cells only in the
high anti-SWAP IgE responders (Figure 5). Based on pre-
vious findings studying Th2 phenotype and development
[34], as well as parallel control of IL-4 and IL-5 producing
cells in human schistosomiasis [35], it is likely that the
same cells are producing these cytokines. It is formally
possible that they come from distinct cells of a partial Th2
like phenotype that are under the same control. However,
given that the IL-4 producing cells did not produce IFN-γ
and vice versa, we have shown a true Th2 type polarization
in these individuals (Figure 3). Many studies in vitro have
demonstrated the ability of sub-populations of T cells to
effect the development of neighboring cells in culture. In
addition, the elucidation of the cytokine profile and bal-
ance between key immunoregulatory cytokines in these
individuals should help in approaches designed to ma-
nipulate the cytokine profile and immune response in in-
fected individuals or in vaccine development. The
question as to whether these individuals have some pre-
disposition to develop the high IgE phenotype, and if this
predisposition was in fact the expression of a higher fre-
quency of cells producing IL-4 and IL-5, has not been re-
solved. Moreover, it is possible that in these individuals
some factor(s) other than gender, age, intensity of infec-
tion, and number of previous treatments may have led to
presentation of antigens in such a way as to generate the
high anti-SWAP IgE response. Further studies looking at
sub-populations of T cells and their responses over time
may help to clarify these questions. In conclusion, these
studies demonstrate an ongoing active production of IL-4
by Th2 like cells in the absence of Th0 cells.
Conclusions
These studies demonstrate that the increase in IL-4 pro-
duction in IgE high responder schistosomiasis patients
comes from true Th2 like cells and not from Th0 cells.
Moreover, this active Th2 polarization takes place without
a decrease (or increase) in the frequency of IFN-γ  or IL-2
producing cells. Thus, a specific increase in the frequency
of true Th2 like cells (not Th0) accompanies the high IgE
responder profile seen in human schistosomiasis, demon-
Figure 4
Lymphocytes from IgE high responder (n = 9)
patients have a higher frequency of IL-4 and IL-5
expressing cells than the IgE low responder (n = 9)
patients. Lymphocytes from the two groups of individuals
were stimulated for a total of 11 h with anti-CD3, CD28, and
IL-2 and stained with anti-IL-4-PE and IFN-γ -FITC or anti-IL-
5-PE and IL-2-FITC as described in Materials and Methods.
The data represent the mean percent of lymphocytes
expressing the indicated cytokine from the two groups with
their standard error. * p < 0.05 using students T test.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/8
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The individuals analyzed in this study were volunteers,
part of a large study group from the S. mansoni endemic
area of Corrego do Bernardo, MG, Brazil. All patients pre-
sented with the intestinal clinical form, as determined by
health exams including an overall physical and palpation
for symptoms of hepatosplenic disease. Any individuals
that presented with positive feces exams were treated, in-
dependent of the participation in this study. Intestinal
schistosomiasis patients were analyzed for anti-SWAP IgE
and IgG responses and two groups were established. One
group was composed of 9 individuals presenting high tit-
ers of IgE anti-SWAP (OD greater than 0.1) and the second
group had 9 individuals that produced low levels of these
specific antibodies (OD lower than 0.1). This cutoff was
determined as described by Webster et al. [36], based on
the limits of detection and the range of values of the ELI-
SA. The levels of IgG anti-SWAP did not vary between
groups. Additionally, as described by Webster et al.[36],
the subset of individuals used in this study were selected
based on gender and age and were found to be statistically
equivalent based on race, egg burden, number of previous
treatments, and co-infection with hook-worm.
In vitro proliferative analysis
In vitro proliferative responses of peripheral blood mono-
nuclear cells (PBMC) were performed according to the
protocol described by Gazzinelli et al [18]. Briefly, PBMC
Figure 5
Coordinate regulation of the frequency of IL-4 and IL-5 expressing lymphocytes from high or low anti-SWAP
IgE responders. The data is presented in a correlation plot considering IL-4 and IL-5 or IFN-γ  and IL-2 for individual patients
from the IgE low (A,C) and high (B,D) groups. The correlation coefficient was calculated using Jump Statistics program.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/8
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obtained by separating blood cells in a Ficoll gradient
were washed 3 times in media, counted and cultured in
the presence or absence of different stimuli for 5 days at
the concentration of 2.5 ×  105cells/well. Stimuli used in
the cultures included SEA, SWAP, (both at 25 ug/ml final
concentration) and, as a positive control, the superantigen
SEB (at 0.5 ug/ml final concentration). After the incuba-
tion period, cultures were exposed to 0.5 mCi of 3[H]-thy-
midine for 6 hours, harvested and the incorporated
radioactivity measured in an automatic scintillation coun-
ter. All cultures were performed in triplicate. Proliferative
response was calculated using the mean of triplicate cul-
tures with antigen minus the mean of triplicate cultures
with medium alone (∆ cpm) for each individual patient.
Ex vivo analysis of lymphocyte profiles
2 ×  105 PBMC from schistosomiasis patients were incu-
bated with FITC or PE-labeled antibody solutions for 20
minutes at 4°C. Then, preparations were washed with
0.1% sodium-azide phosphate buffered saline, fixed with
200 ul of 1% paraformaldehyde 1% sodium cacodilate-
NaCl and kept cold until data acquisition using a FACS-
can. The antibodies used for the staining were anti-CD4-
PE, anti-CD8-PE, anti-HLA-DR-FITC, anti-CD19-PE, and
Ig-FITC and PE controls, all purchased from Immunotech
(Birmingham, UK).
Single cell cytoplasmic cytokine analysis
Lymphocytes were analysed for their intracellular cy-
tokine expression pattern as described below and by Sor-
naze et al[37]. Briefly, cells frozen in DMSO and normal
human sera as described by Yssel [38], were brought from
the endemic area in Brazil to DNAX Research Institute in
Palo Alto, CA, USA (2 months following the initial collec-
tion of PBMC). Cells were thawed and stimulated in cul-
ture for 7 hours with a combination of anti-CD3 and anti-
CD28 antibodies in presence of IL-2 to reveal their ex vivo
cytokine profile. Cultures were exposed to Brefeldin for a
period of at least 4 hours. The cells were then fixed using
formaldehyde, permeabilized with a solution of saponin
and stained using anti-cytokine mAbs directly conjugated
with either FITC (IFN-γ  and IL-2) or PE (IL-4 and IL-5) us-
ing the pairs of IFN-γ  and IL-4 or IL-2 and IL-5 for 30 min-
utes at 4°C. Preparations were washed and fixed as
described in the previous section and analyzed in a FACS-
calibur, selecting the lymphocyte population. 30,000.00
events were counted. FITC and PE-labeled Ig control anti-
bodies as well as a control of unstimulated PBMC were
also included in all experiments. In addition, the cells
where submitted to a confirmatory analysis using the
same surface markers used on the fresh lymphocytes taken
from the individuals (see above). This analysis did not
show significant differences in the percent of CD4+,
CD8+, or CD19+ cells as compared to the before freezing
analysis. A recovery of 70% of the cells, on average, was
achieved using the slow freezing and quick thaw method
described by Yssel [38].
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